GNB3 Gene - G Protein Subunit Beta 3
Key regulator of G protein signaling in hypertension and metabolic disorders
Gene Information Card
| Symbol | GNB3 |
|---|---|
| Full Name | G protein subunit beta 3 |
| Gene Type | protein-coding |
| Chromosomal Location | 12p13.31 |
| NCBI Gene ID | 2784 ncbi.nlm.nih.gov/gene/2784 |
| Ensembl ID | ENSG00000111664 |
| UniProt ID | P16520 |
| OMIM ID | 139130 |
| HGNC ID | 4400 |
| Aliases | MGC102957, MGC102958, MGC102959 |
Description
The GNB3 gene encodes the beta-3 subunit of heterotrimeric G proteins, which are critical components of intracellular signal transduction pathways. G proteins mediate signals from G protein-coupled receptors (GPCRs) to downstream effectors such as adenylyl cyclase and ion channels. The beta-3 subunit forms a dimer with the gamma subunit and modulates receptor coupling and effector activation. A common polymorphism (C825T) in GNB3 is associated with alternative splicing and altered signaling, linked to essential hypertension, obesity, and other cardiovascular and metabolic traits.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Essential hypertension | C825T polymorphism leads to enhanced G protein signaling and increased vascular reactivity | Multiple association studies; meta-analyses confirm significant risk (OR ~1.2-1.5) |
| Obesity | Altered beta-3 subunit expression affects adipocyte signaling and energy metabolism | Case-control studies; association with body mass index and fat distribution |
| Type 2 diabetes | Impaired insulin signaling via G protein pathways | Some cohort studies show increased risk in carriers of 825T allele |
| Coronary artery disease | Enhanced platelet activation and vascular smooth muscle proliferation | Observational studies; modest effect size |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Adipose tissue | 15.2 | Medium |
| Heart | 12.8 | Medium |
| Brain | 10.5 | Medium |
| Liver | 8.3 | Low |
| Kidney | 11.1 | Medium |
| Lung | 9.7 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HEK293 | 18.4 | High expression; commonly used for functional studies |
| HeLa | 14.2 | Moderate expression |
| HepG2 | 9.8 | Low expression |
| K562 | 7.5 | Low expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| C825T (rs5443) | SNP | 30-40% in European populations; higher in Asian populations | Alternative splicing; increased G protein activation |
| A350G (rs5442) | SNP | ~10% in various populations | Missense; functional impact unclear |
| c.825C>T | SNP | Common | Associated with hypertension and obesity |
Mutation functional classification
Loss of Function (LOF)
No well-characterized loss-of-function mutations reported in GNB3.
Gain of Function (GOF)
C825T polymorphism is associated with enhanced G protein signaling (gain-of-function) due to alternative splicing producing a truncated but hyperactive beta-3 subunit.
Dominant Negative (DN)
Not described for GNB3.
View complete mutation data:
Gene Ontology (GO)
| • signal transducer activity (GO:0004871) | • heterotrimeric G-protein complex (GO:0005834) |
| • G protein-coupled receptor signaling pathway (GO:0007186) | • G-protein beta/gamma-subunit complex (GO:0031683) |
| • intracellular membrane-bounded organelle (GO:0043231) |
Pathways
• GPCR signaling pathway (Reactome: R-HSA-372790)
• G alpha (i) signaling events (Reactome: R-HSA-418594)
• G alpha (s) signaling events (Reactome: R-HSA-418555)
• Adrenergic signaling in cardiomyocytes (KEGG: hsa04261)
Protein Summary
The GNB3 protein (UniProt P16520) is a 340-amino acid beta subunit of heterotrimeric G proteins. It contains seven WD40 repeats that form a beta-propeller structure, mediating interactions with G alpha and G gamma subunits. The protein is ubiquitously expressed with highest levels in adipose tissue, heart, and brain. The C825T polymorphism (rs5443) results in alternative splicing, producing a truncated protein (Gbeta3-s) that exhibits enhanced signaling activity. This gain-of-function variant is associated with essential hypertension, obesity, and related metabolic disorders. GNB3 is not currently a major target in cancer genomics (COSMIC data limited).
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| GNB3 Knockout HEK293 Cell Line | EDJ-KQ800 | Human | 2784 | Details Get a Quote |
| GNB3 Knockout HeLa Cell Line | EDJ-KQ18354 | Human | 2784 | Details Get a Quote |
| GNB3 Knockout A-549 Cell Line | EDJ-KQ19527 | Human | 2784 | Details Get a Quote |
| GNB3 Knockout HCT 116 Cell Line | EDJ-KQ19528 | Human | 2784 | Details Get a Quote |